-
Views
-
Cite
Cite
Roberto Scacciavillani, Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?, European Heart Journal, Volume 45, Issue 25, 1 July 2024, Page 2263, https://doi.org/10.1093/eurheartj/ehae274
- Share Icon Share
Extract
This commentary refers to ‘Electrical storm treatment by percutaneous stellate ganglion block: the STAR study’, by S. Savastano et al., https://doi.org/10.1093/eurheartj/ehae021 and the discussion piece ‘Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm’, by S. Savastano et al., https://doi.org/10.1093/eurheartj/ehae276.
The authors of the article ‘Electrical storm treatment by percutaneous stellate ganglion block: the STAR study’, appearing in the latest issue of the European Heart Journal must be praised for presenting the largest prospective study to date of patients (131) receiving percutaneous stellate ganglion block (PSGB) for the treatment of refractory electrical storm (ES).1 They demonstrate an outstanding acute success rate of 92% in reducing by at least 50% treated arrhythmic events comparing the 12 h following PSGB with the 12 h before the procedure, with the possibility to repeat it or give continuous infusion in case of unsatisfactory outcome. However, some major concerns need to be addressed.